Weijia Fu

Ms. Weijia Fu


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2026 in Endocrines
Verified
Journal Article
Open access
PDF file
MDMoitrayee Dhar
Moitrayee Dhar
SASeungjun Ahn
Seungjun Ahn
WFWeijia Fu
Weijia Fu
WGWhitney Goldner
Whitney Goldner
MMMathilda Monaghan
Mathilda Monaghan
Maaike van GerwenMaaike van Gerwen
Maaike van Gerwen
Background/Objectives: The increasing incidence of thyroid cancer in the United States suggests a possible role for environmental exposures that potentially alter thyroid hormone regulation through cellular toxicity. 2,4-Dichlorophenoxyacetic acid (2,4-D) is a commonly used herbicide that can act as an endocrine disruptor and may be toxic to the thyroid gland. This ecological study examined county-level associations of 2,4-D use and age-adjusted incidence of thyroid cancer in the United States. Methods: The study utilized age-adjusted incidence rates for thyroid cancer for 2017–2021 through the CDC database. County-level 2,4-D use data was obtained from the U.S. Geological Survey and averaged over two time periods: 2003–2007 (10-year lag) and 2008–2012 (5-year lag). The association between 2,4-D use and thyroid cancer incidence was tested using linear mixed effects models. We further stratified the data analyses by sex and rurality (using the Rural–Urban Continuum Codes, RUCC 6–9 codes). For this study, statistical significance was set at p < 0.05. Results: In nationwide analyses, no significant associations were found in combined (5-year lag: p = 0.218; 10-year lag: p = 0.276) and sex-stratified models (males: p = 0.540 and p = 0.497; females: p = 0.222 and p = 0.353, for the 5- and 10-year lags, respectively). In analyses limited to rural counties, 2,4-D exposure was significantly associated with greater thyroid cancer incidence for both the 5-year (p = 0.004) and 10-year (p = 0.006) lag periods for the total population. Conclusions: The strong associations observed in rural counties suggest that agricultural context may influence the observed relationship between county-level 2,4-D use and thyroid cancer incidence. Additional mechanistic and longitudinal studies are required to establish causality and to elucidate underlying endocrine pathways.

Verified
Journal Article
Open access
PDF file
NMNihal Mohamed
Nihal Mohamed
JNJean Claude Andre Noel
Jean Claude Andre Noel
DSDanielle Scharp
Danielle Scharp
WFWeijia Fu
Weijia Fu
HJHimanshu Joshi
Himanshu Joshi
AGAdam Gonzalez
Adam Gonzalez
Background/Objectives: Active surveillance (AS) is the recommended management strategy for localized, early-stage prostate cancer. Despite promising cancer-specific outcomes, up to one-third of men discontinue AS and undergo radical prostatectomy without evidence of disease progression, often because of stress, anxiety, uncertainty, and unmet supportive care needs. Evidence-based psychosocial interventions tailored to men on AS are lacking. We aimed to: (1) adapt the Stress Management and Resilience Training (SMART) program to address the unique psychosocial and supportive care needs of men with prostate cancer on AS (SMART-AS), and (2) evaluate the feasibility and acceptability of SMART-AS. Methods: Following the Assessment, Decision, Adaptation, Production, Topical Experts, Integration, Training, Testing (ADAPT-ITT) framework, we adapted SMART for men with prostate cancer on AS (SMART-AS) informed by our prior qualitative study and expert input. Next, we conducted a single-arm pilot feasibility study at one large urban academic medical center. Participants attended eight weekly 90-minute telehealth group SMART-AS sessions. Feasibility and acceptability were evaluated one-week post-intervention. Results: Based on our prior qualitative study and expert input, core SMART-AS components included content targeting stress, anxiety, communication, and self-management. In total, 30 participants were enrolled in the pilot feasibility study and completed baseline assessments (mean age = 71 years, standard deviation = 8.3); 26/30 (86.7%) completed six out of eight SMART-AS sessions, and 17/30 (56.7%) completed post-intervention assessments. Nearly all (16/17, 94.1%) reported that they would recommend SMART-AS to others. Most agreed that SMART-AS helped them talk to clinicians (13/17, 76.5%), reduced anxiety (13/17, 76.5%), enhanced coping skills for AS challenges (15/17, 88.2%), and supported self-care (15/17, 88.2%). Nearly two-thirds (11/17, 64.7%) reported SMART-AS helped them continue AS as a management strategy. Conclusions: This pilot study provides preliminary evidence supporting the feasibility and acceptability of SMART-AS among men with prostate cancer on AS. Participants reported perceived improvements in anxiety, coping, communication with clinicians, and self-management. Findings support further evaluation in a randomized controlled trial.